Memantine Hydrochloride Tablet
Product Images NDC 27241-070

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 27241-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-figure1 (Memantine Figure1)

The text describes a chart or graph showing the mean change from baseline in ADCS-ADL score for patients undergoing 12 weeks of treatment with either placebo or memantine hydrochloride. The chart may also show a clinical decline.*

FDA Label Image

Memantine-figure3 (Memantine Figure3)

FDA Label Image

Memantine-figure5 (Memantine Figure5)

This is the description of a clinical trial for Alzheimer's disease. The focus is on the change in the ADCS-ADL score for patients given either a placebo or memantine hydrochloride /donepezil over the course of several weeks. The mean change from baseline is represented graphically with error bars given by the standard error of the mean (SEM).*

FDA Label Image

Memantine-figure7 (Memantine Figure7)

This appears to be a visual of a graph displaying the mean change from baseline in SIB score over weeks of treatment with placebo, donepezil, and memantine hydrochloride donepezil. The x-axis appears to represent the weeks of treatment and the y-axis appears to represent the change in SIB score. The graph shows that both donepezil and memantine hydrochloride donepezil resulted in an improvement in SIB score compared to placebo. However, without more context and information, it is difficult to provide a more detailed description or analysis.*

FDA Label Image

Memantine_structure (Memantine Structure)

FDA Label Image

Memantine-10mg (Memantine 10mg)

This is a description of a drug called "Memantine Hydrochloride USP" with a strength of 10mg per tablet. Each film-coated tablet comes in a package of 60 tablets. There is a pending USP Assay test. The package is child-resistant, and the tablets should be kept in a tightly closed container as described in the USP. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F). The package insert should be consulted for dosing and prescribing information. The drug is marketed by Ajanta Pharma USA Inc, located in Bridgewater, NJ.*

FDA Label Image

Memantine-5mg (Memantine 5mg)

This is a description of a package of film-coated tablets that contain 5mg of Memantine Hydrochloride in each tablet. The tablets come in a child-resistant package with instructions to keep them away from children. The tablets should be stored in a tightly closed container at a controlled room temperature between 15°C to 30°C (59°F to 86°F). There is a pending USP assay test and the package insert should be read for full prescribing information. The tablets are marketed by Ajanta Pharma USA Inc. and made in India.*

FDA Label Image

Memantine-figure2 (Memantine Figure2)

FDA Label Image

Memantine-figure4 (Memantine Figure4)

FDA Label Image

Memantine-figure6 (Memantine Figure6)

FDA Label Image

Memantine-figure8 (Memantine Figure8)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.